Stockscreener 앱 받기
0.3064
7.29%
-0.0241
시간 외 거래:
.30
-0.0064
-2.09%
전일 마감가:
$0.3305
열려 있는:
$0.3206
하루 거래량:
643.61K
Relative Volume:
0.15
시가총액:
$10.05M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-25.27%
1개월 성능:
-42.15%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.3023
$0.33
1주일 범위
$0.3023
$0.41
52주 변동 폭
$0.3023
$2.22
Profusa Inc Stock (PFSA) Company Profile
명칭
Profusa Inc
전화
212-494-9022
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
PFSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.3064 | 11.18M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Profusa Inc 주식(PFSA)의 최신 뉴스
Profusa Approves $100 Million Equity Line of Credit - MSN
Profusa shareholders approve $100 million equity line of credit with Ascent Partners By Investing.com - Investing.com South Africa
Profusa shareholders approve $100 million equity line of credit with Ascent Partners - Investing.com Australia
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base - GlobeNewswire
300+ CLTI Patients Annually: Profusa's Oxygen Monitoring Tech Enters Major Belgian Hospital - Stock Titan
Profusa's Strategic Position in Digital Health Innovation - AInvest
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Digital Health Pioneer Profusa to Showcase Continuous Biochemistry Monitoring Tech at Major Conference - Stock Titan
Profusa announces commercial and clinical collaboration with head of angiography, Medical University of Graz, Austria - MarketScreener
Profusa Announces Commercial and Clinical Collaboration - GlobeNewswire
Leading Vascular Center Adopts Profusa's Real-Time Oxygen Monitoring Tech for 1,500 Annual Procedures - Stock Titan
Profusa amends purchase agreement and note terms for convertible debt tranches - Investing.com Australia
Profusa Restructures Securities Agreement for Enhanced Flexibility - AInvest
Profusa Restructures Securities Agreement for Flexibility - MSN
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Profusa Stock Soars 33.88% on Leadership Shakeup, Expansion - AInvest
Profusa Appoints New CFO and Lead Director - TipRanks
Profusa, Inc. shares fall 8.88% intraday despite adding seasoned finance executive Fred Knechtel as CFO. - AInvest
Profusa adds former VA chief and Fortune 500 executive to leadership - Investing.com
Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O’Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO - The Manila Times
Profusa Welcomes Former Acting U.S. Veterans Affairs - GlobeNewswire
Profusa, Inc. Appoints Fred Knechtel as CFO - MarketScreener
Profusa, Inc. shares rise 4.26% premarket after announcing a distributor for its tissue oxygen technology. - AInvest
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform - MarketScreener
Profusa announces initial $1 million bitcoin investment to initiate its digital asset treasury strategy - MSN
Profusa, Inc. SEC 10-Q Report - TradingView
Profusa Announces Nasdaq Listing and Growth Plans - TipRanks
Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang - AlphaStreet
Profusa shares strategy update as it transitions to public company By Investing.com - Investing.com South Africa
Profusa shares strategy update as it transitions to public company - Investing.com India
Profusa, Inc. Outlines Growth Strategy and Milestones in Shareholder Letter Following Nasdaq Listing - Quiver Quantitative
Profusa Achieves Milestones, Commits to Groundbreaking Biochemistry Tech. - AInvest
Profusa, Inc. Provides Strategy Overview and Business Update for Investors - Bluefield Daily Telegraph
Profusa Reports Q1 2026 Commercial Launch in Europe for Tissue Oxygen Monitoring Platform - AInvest
Digital Health Pioneer Profusa Unveils $10B Market Strategy for Biochemistry Platform | PFSA Stock News - Stock Titan
Profusa, Inc. Secures Lumee?? Oxygen Platform Distributor in Spain - MarketScreener
Profusa signs LOI for distribution of Lumee Oxygen platform in Spain - Investing.com Australia
Profusa Secures Lumee™ Oxygen Platform Distributor in Spain - The Manila Times
Profusa Signs Letter of Intent for Lumee Oxygen Distribution in Spain. - AInvest
Profusa Targets 300,000 Annual European Procedures with Spanish Distribution Partnership - Stock Titan
Profusa stock falls after announcing $1 million Bitcoin investment By Investing.com - Investing.com South Africa
Profusa invests $1 million in bitcoin as part of treasury strategy By Investing.com - Investing.com Nigeria
Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy - The Manila Times
Profusa Inc (PFSA) 재무 분석
Profusa Inc (PFSA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.78%
0.31%
자본화:
|
볼륨(24시간):